Kindred Healthcare Inc. (KND) Trading Down 4.5%
Kindred Healthcare Inc. (NYSE:KND) shares traded down 4.5% during trading on Monday . The company traded as low as $11.69 and last traded at $11.71, with a volume of 475,771 shares trading hands. The stock had previously closed at $12.26.
A number of research analysts recently commented on the company. Avondale Partners reissued a “hold” rating on shares of Kindred Healthcare in a report on Saturday, June 18th. TheStreet raised Kindred Healthcare from a “sell” rating to a “hold” rating in a report on Monday, April 11th. Zacks Investment Research downgraded Kindred Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, July 27th. Finally, Mizuho increased their price target on Kindred Healthcare from $9.00 to $13.50 and gave the company a “neutral” rating in a report on Thursday, May 5th. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $14.00.
The stock has a market cap of $993.79 million and a P/E ratio of 15.34. The company has a 50-day moving average price of $11.71 and a 200-day moving average price of $11.62.
Kindred Healthcare (NYSE:KND) last released its quarterly earnings data on Wednesday, May 4th. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.13. The firm had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period in the previous year, the business posted $0.43 EPS. Kindred Healthcare’s revenue for the quarter was up 9.7% on a year-over-year basis. On average, analysts expect that Kindred Healthcare Inc. will post $0.92 earnings per share for the current year.
In other Kindred Healthcare news, CAO John Joseph Lucchese sold 4,341 shares of the firm’s stock in a transaction dated Wednesday, June 29th. The stock was sold at an average price of $11.39, for a total transaction of $49,443.99. Following the transaction, the chief accounting officer now directly owns 34,130 shares in the company, valued at $388,740.70. The transaction was disclosed in a filing with the SEC, which is available through this link.
A number of institutional investors recently bought and sold shares of KND. Wells Fargo & Company MN raised its position in Kindred Healthcare by 520.3% in the fourth quarter. Wells Fargo & Company MN now owns 863,118 shares of the company’s stock valued at $10,280,000 after buying an additional 723,970 shares during the period. Morgan Stanley raised its position in Kindred Healthcare by 49.4% in the fourth quarter. Morgan Stanley now owns 1,189,407 shares of the company’s stock worth $14,166,000 after buying an additional 393,128 shares during the last quarter. Advisors Asset Management Inc. acquired a new position in Kindred Healthcare during the fourth quarter worth approximately $3,485,000. Royce & Associates LLC raised its position in Kindred Healthcare by 37.0% in the fourth quarter. Royce & Associates LLC now owns 185,000 shares of the company’s stock worth $2,203,000 after buying an additional 50,000 shares during the last quarter. Finally, Mutual of America Capital Management LLC raised its position in Kindred Healthcare by 34.5% in the fourth quarter. Mutual of America Capital Management LLC now owns 114,024 shares of the company’s stock worth $1,358,000 after buying an additional 29,232 shares during the last quarter.
Kindred Healthcare, Inc is a healthcare services company. The Company operates through four divisions, including the hospital division, the Kindred at Home division, the Kindred Rehabilitation Services division and the nursing center division. Its divisions represent over six segments, including hospitals, home health services, hospice services, Kindred Hospital Rehabilitation Services, RehabCare and nursing centers.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.